Skip to main content

SUSQUEHANNA INTERNATIONAL GROUP, LLP

Position in CRDL — Cardiol Therapeutics Inc.

CIK 1446194 BALA CYNWYD, PA

Position in CRDL

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$0
-$95,033 QoQ
Shares Held
0
-100.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Dec 2021
16 quarters on record

Common Shares in CRDL Over Time

Shares Held

Position Value (USD)

Derivatives in CRDL

reported options exposure · as of Jun 30, 2026
CallValue
$27,348
CallShares
25,800
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

SUSQUEHANNA INTERNATIONAL GROUP, LLP holds $269,786,604 across 51 Drug Manufacturers - Specialty & Generic names.

# Ticker Company Shares Value (USD) Open

All Filings in CRDL

Export CSV
20 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $27,348 25,800
2026-03-31 $95,033 70,396
2025-12-31 $194,354 203,726
2025-09-30 $99,935 93,398
2025-06-30 $27,231 20,023
2024-12-31 $22,225 17,364
2024-09-30 $50,185 25,346
2024-06-30 $133,683 66,180
2024-06-30 $268,660 133,000
2024-03-31 $68,780 38,000
2024-03-31 $82,660 45,669
2023-12-31 $14,668 17,400
2023-06-30 $32,585 36,613
2023-03-31 $51,854 106,477
2022-09-30 $19,802 19,226
2022-06-30 $17,944 13,594
2022-03-31 $133,110 87,000
2022-03-31 $19,813 12,950
2021-12-31 $77,330 41,800
2021-12-31 $217,005 117,300